Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
FDA grants Verastem first approval for rare ovarian cancer treatment
6 days ago
FDA+
FDA will convene vaccine advisors to discuss Covid strain updates
Last week
FDA+
Gilead reveals plans to put another $11B into US manufacturing
Last week
R&D
Manufacturing
Teva plans staff cuts as it commits to accelerating growth
Last week
Manufacturing
PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments
Last week
Manufacturing
FDA's ODAC will review drugs for four different cancers at meeting in May
Last week
FDA+
Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling
Last week
Law
From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices
Last week
Compounders just lost their case to put obesity drug tirzepatide back in shortage
Last week
Law
Health Tech
What Vinay Prasad means for CBER, vaccines, drug approvals and more
Last week
FDA+
Novo Nordisk trims growth forecast as GLP-1 compounder ban yet to go live
Last week
Sarepta’s stock plummets after Prasad appointment, low Elevidys sales
Last week
FDA+
States sue US over plan for reorganization of federal health agencies
Last week
Law
Trump, Congress look at matching some US drug prices to costs abroad
Last week
Trump, FDA zero in on foreign factories to give domestic sites an edge
Last week
FDA+
Manufacturing
Europe pledges €500M to attract global science talent
Last week
People
Vertex touts promising first few months of launch for non-opioid pain drug Journavx
Last week
New opioid data may not be generalizable, FDA adcomm says
Last week
FDA+
FDA adcomm will review Capricor's cell therapy for Duchenne muscular dystrophy
Last week
Cell/Gene Tx
FDA+
Bristol Myers to lay off over 500 workers in New Jersey
Last week
People
Even as questions grow over RFK Jr.'s vaccine policy, BioNTech doesn't see ‘near-term’ impact
Last week
R&D
FDA+
White House budget request would cut billions at NIH and CDC, add $500M for MAHA
Last week
FDA+
FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers
Last week
R&D
FDA+
Missing REMS delays Cytokinetics' heart drug PDUFA, stock drops
Last week
FDA+
First page
Previous page
1
2
3
4
5
Next page
Last page